Följ oss

Nyheter

A closer look at emerging market equities

Publicerad

den

A closer look at emerging market equities

ETF Securities Portfolio Insights:  A closer look at emerging market equities

Summary

  • Global equities have been rallying in 2017, led by Asian emerging countries and North America to a lesser extent.
  • The IMF expects Asian economies to continue to drive global growth while central banks in advanced economies are gradually reducing their financial support.
  • We believe US equities are overvalued and see greater opportunities within Latin American and Asian equities for 2018.

Global equities have been rallying since the end of 2016 as strong economic data from major advanced and developing countries combined with a decline in perceived political uncertainty has led to a surge of optimism on the global financial market. Extremely accommodative monetary policies in place since the great financial crisis are bearing fruit. 2018 will likely see these accommodative policies gradually dismantled, opening the path to new investment opportunities.

2017 performance

This year has seen global equities rallying since November 2016 as market participants are more confident that global economic growth has returned and will continue. While few risks remain, with the Italian election next year and the ongoing fight against terrorism and North Korea, the populist threat seen in 2016 has faded away. Unemployment is near its lowest in the US and UK with central banks now focussing on dismantling quantitative easing and tackling the inflation issue.

Looking at 2017 performance so far, the MSCI AC World index rose by 22%, driven by the rally of emerging markets (EM) and more specifically, emerging countries from Asia (39%). The developed markets (DM) with North America come second at 19.5%, followed by emerging Latin America at 18.5%. While one would expect volatility to pick up, 2017 saw the market volatility index (VIX) at its lowest level ever, at 9.6 on average, compared to 20 its historical average, suggesting that investors could increase their allocation to equities almost risk free.

Of the top 20 performers, 75% are emerging market countries. Argentina is leading the board with 62.6% year-to-date while China comes fourth (52%) and India eleventh (25.7%).

In its October World Economic Outlook, the International Monetary Fund (IMF) estimated global growth at 3.6% in 2017 and 3.7% in 2018 from 3.2% in 2016 driven by rising industrial activities and business and consumer confidence. Global growth will be mainly driven by EM countries projected at 4.6% in 2017 and 4.9% in 2018. China GDP has been revised upward by 0.2% compared to April, at 6.8% in 2017 and 6.5% in 2018 while India GDP for 2017 was revised down from 7.2% to 6.7%. In Latin America, Argentina is expected to rebound after last year’s recession with growth projected at 2.5% for 2017 and 2018 as consumption and investment recover.

What are the ratios saying?

The cyclically adjusted price to earnings ratio (CAPE) of DM over EM shows that developing countries remain attractive from a valuation point of view. Whilst the MSCI Emerging Market index has returned 30% year-to-date, the below chart suggests there is still scope for further gains in 2018.

In the following chart, the Latin American countries Argentina, Brazil, Colombia, Mexico and Chile, appear to be the most undervalued. Despite prices for these countries rising by 23% on average, the CAPE ratio remains below their respective historical averages driven by lower-than-average real earnings. However, all except Chile saw their real earnings growing this year in absolute terms, suggesting further potential catch-up of their earnings in the near term.

At the other end of the spectrum, US, Japan and few European countries are considered as overvalued. The CAPE ratio for each stands above their historical level due to real earnings having already catched up with its respective historical level and price rally. Further gains would be more difficult to justify.

A closer look at China

Xi Jinping came out of the 19th Congress of the Chinese Communist Party stronger than ever. Elevated to the same level as Mao Zedong, the president of the Republic of China has been given more power than any of his contemporary predecessors and with no one in its close committee potentially qualified to replace him in five years. With Xi having a history of stalling reform, we may see the implementation of short term stimulus, as opposed to long term structural reforms, continue. This should be positive for Chinese equities as the country focuses on sustainable growth, attracting foreign investment and remaining the largest consumers of commodities to meet the need of its economy and population. The outcome has initially been positively received as the MSCI China Index gained 8% one month following the Congress before declining recently as Chinese economic activities continue to show signs of a mild slowdown.

The above chart shows that China CAPE ratio currently stands above its historical level, suggesting that Chinese equities are overvalued. However, the surge of the MSCI China Index price level has been the main driver of the increase in the CAPE ratio. The index real earnings per share have been below its historical average over the past two years but are gradually recovering toward its mean since the beginning of the year. This picture combined with the potential decade length investiture of the “Strongman” suggests further potential upside for Chinese equities in the medium term.

Non-resident capital inflows in EM, mainly China, reached a bottom in 2015, according to the IMF, on concerns over the impact the US taper tantrum could have on EM asset prices and the potential depreciation of the Yuan. Inflows have revived since but is still half of the volume seen at its peak in Q1 2013. The recovery of investor sentiment regarding the global economy should see capital inflows in EM assets increase further in 2018.

Important Information

This communication has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by ETF Securities (UK) Limited (“ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (the “FCA”).

Fortsätt läsa
Annons
Klicka för att kommentera

Skriv en kommentar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *

Nyheter

Fastställd utdelning i MONTDIV april 2025

Publicerad

den

Idag fastställdes utdelningen i MONTDIV april 2025. Montrose Global Monthly Dividend MSCI World UCITS ETF (MONTDIV ETF) fastställdes till 0,39465 kronor per andel. Utdelningen i MONTDIV april 2025 beräknas betalas ut den 12 maj 2025.

Idag fastställdes utdelningen i MONTDIV april 2025. Montrose Global Monthly Dividend MSCI World UCITS ETF (MONTDIV ETF) fastställdes till 0,39465 kronor per andel. Utdelningen i MONTDIV april 2025 beräknas betalas ut den 12 maj 2025.

Handla MONTDIV ETF

Montrose Global Monthly Dividend MSCI World UCITS ETF (MONTDIV ETF) är en europeisk börshandlad fond. Denna fond handlas på Nasdaq Stockholm.

Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel  NordnetSAVRDEGIRO och Avanza.

Fortsätt läsa

Nyheter

WELG ETF en satsning på healthcareföretag världen över

Publicerad

den

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) (WELG ETF) med ISIN IE000JKS50V3, strävar efter att spåra S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. Det S&P-utvecklade ex-Korea LargeMidCap Sustainability Enhanced Health Care-indexet spårar stora och medelstora företag från hälso- och sjukvårdssektorn. Aktierna som ingår filtreras enligt ESG-kriterier (miljö, social och bolagsstyrning).

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) (WELG ETF) med ISIN IE000JKS50V3, strävar efter att spåra S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. Det S&P-utvecklade ex-Korea LargeMidCap Sustainability Enhanced Health Care-indexet spårar stora och medelstora företag från hälso- och sjukvårdssektorn. Aktierna som ingår filtreras enligt ESG-kriterier (miljö, social och bolagsstyrning).

Den börshandlade fondens TER (total cost ratio) uppgår till 0,18 % p.a. Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) är den billigaste ETF som följer S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. ETFen replikerar det underliggande indexets prestanda genom fullständig replikering (köper alla indexbeståndsdelar). Utdelningarna i ETFen delas ut till investerarna (Årligen).

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) är en mycket liten ETF med 17 miljoner euro förvaltade tillgångar. ETFen lanserades den 20 september 2022 och har sin hemvist i Irland.

Investeringsmål

AMUNDI S&P GLOBAL HEALTH CARE ESG UCITS ETF DR – EUR (D) försöker replikera, så nära som möjligt, resultatet av S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index (Netto Total Return Index). Denna ETF har exponering mot stora och medelstora företag i utvecklade länder. Den innehåller uteslutningskriterier för tobak, kontroversiella vapen, civila och militära handeldvapen, termiskt kol, olja och gas (inkl. Arctic Oil & Gas), oljesand, skiffergas. Den är också utformad för att välja ut och omvikta företag för att tillsammans förbättra hållbarhet och ESG-profiler, uppfylla miljömål och minska koldioxidavtrycket.

Handla WELG ETF

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) (WELG ETF) är en europeisk börshandlad fond. Denna fond handlas på flera olika börser, till exempel Deutsche Boerse Xetra.

Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel DEGIRONordnet, Aktieinvest och Avanza.

Börsnoteringar

BörsValutaKortnamn
gettexEURWELG
XETRAUSDWELZ
XETRAEURWELG

Största innehav

Denna fond använder fysisk replikering för att spåra indexets prestanda.

NamnValutaViktSektor
ELI LILLY & COUSD10.29 %Health Care
UNITEDHEALTH GROUP INCUSD7.99 %Health Care
NOVO NORDISK A/S-BDKK6.32 %Health Care
ABBVIE INCUSD6.12 %Health Care
ASTRAZENECA GBPGBP5.26 %Health Care
ROCHE HOLDING AG – GENUSSSCHF4.18 %Health Care
MERCK & CO. INC.USD3.93 %Health Care
NOVARTIS AG-REGCHF3.70 %Health Care
ABBOTT LABORATORIESUSD3.43 %Health Care
SANOFIEUR2.58 %Health Care

Innehav kan komma att förändras

Fortsätt läsa

Nyheter

Amundi noterar ETF för globala företagsobligationer

Publicerad

den

Amundi Global Corporate Bond UCITS ETF investerar globalt i företagsobligationer med fast ränta, denominerade i lokal valuta och har en investment grade-rating. De måste ha en återstående löptid på minst ett år.

Amundi Global Corporate Bond UCITS ETF investerar globalt i företagsobligationer med fast ränta, denominerade i lokal valuta och har en investment grade-rating. De måste ha en återstående löptid på minst ett år.

Andelsklassen är valutasäkrad mot amerikanska dollar och delar ut avkastningen.

NamnISIN
Kortnamn
KostnadUtdelnings-
policy
Amundi Global Corporate Bond UCITS ETF USD Hedged DistLU2996613266
USBG (USD)
0,17%Utdelande

Produktutbudet inom Deutsche Börses ETF- och ETP-segment omfattar för närvarande totalt 2 405 ETFer, 198 ETCer och 256 ETNer. Med detta urval och en genomsnittlig månatlig handelsvolym på mer än 21 miljarder euro är Xetra den ledande handelsplatsen för ETFer och ETPer i Europa.

Fortsätt läsa

21Shares

Prenumerera på nyheter om ETFer

* indicates required

21Shares

Populära